Evidence map›Paper›PMID 31799409›Full record

ArticleBMJ open ophthalmology2019

Characterisation of vascular changes in different stages of Stargardt disease using double swept-source optical coherence tomography angiography.

Michael Reich, Andreas Glatz, Bertan Cakir, Daniel Böhringer, Stefan Lang, Sebastian Küchlin, Lutz Joachimsen, Wolf Lagreze, Hansjuergen T Agostini, Clemens Lange

Open access · goldAbstract read
In one paragraph

Article in BMJ open ophthalmology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.6field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Michael ReichEye Center, Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany.ORCID 0000-0002-9813-8483
Andreas GlatzEye Center, Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
Bertan CakirEye Center, Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
Daniel BöhringerEye Center, Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
Stefan LangEye Center, Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
Sebastian KüchlinEye Center, Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
Lutz JoachimsenEye Center, Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
Wolf LagrezeEye Center, Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
Hansjuergen T AgostiniEye Center, Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
Clemens LangeEye Center, Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
University of Freiburg · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo describe vascular changes in different stages of Stargardt disease (STGD) via double swept-source optical coherence tomography angiography. METHODS AND ANALYSIS: Prospective, cross-sectional case-control study. Twenty-three patients (45 eyes) with ABCA4 mutations graded according to the Fishman STGD classification and 23 controls (23 eyes) were included. Two independent investigators quantified the foveal avascular zone (FAZ) in the superficial and deep capillary plexus (SCP/DCP) and the areas presenting rarefied flow and complete vascular atrophy in the outer retina to choriocapillaris (ORCC) and choriocapillaris (CC) slab.

resultsThe mean age at first diagnosis of STGD was 24.0 years (range 9-50) and 37.9 years (range 18-74) at the time of examination. Eleven patients were assigned to the Fishman STGD classification stage (S) 1, three to S2, eight to S3 and one to S4. The FAZ in SCP and DCP was increased in all stages compared with controls (p<0.01). Areas with rarefied flow signal and vascular atrophy were detected in the ORCC and the CC layer and grew with increasing stage of disease (p<0.01). The duration of disease correlated with the extent of the enlarged FAZ in the SCP/DCP and with the area of reduced flow in the ORCC and CC layer (p<0.01). Best corrected visual acuity correlated negatively with the extent of the enlarged FAZ in the SCP/DCP (p<0.0001), as well as with enlarged atrophic area in the ORCC and CC layer (p=0.026 and p=0.074).

conclusionsPatients with STGD reveal vascular changes in the retina and CC in all disease stages. The avascular zone in the SCP/DCP and areas with rarefied flow signal in the ORCC/CC increase with the duration and stage of disease, indicating progressive vascular decay most likely secondary to retinal pigment epithelium and neuronal loss. Furthermore, increased vascular damage is associated with decreased vision.

Indexed as

DegenerationDystrophyRetina

Identifiers

PMID31799409
PMCPMC6861074
OpenAlexW2983335476

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.